JACQUELINE PHAM: Open Payments
NPI 1114534542 · MISSION VIEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$521 in 4 payments from 4 companies in 2025. Trend: 2023 $59 · 2024 $305 · 2025 $521
Food & beverage: $521
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 1 | $144 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $129 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Neurocrine BioSciences, Inc. | 1 | $123 |
Products named: REXULTI, CAPLYTA, Auvelity, INGREZZA.
Industry payments across CA — which companies pay providers there.
